1. Home
  2. KELYA vs ELDN Comparison

KELYA vs ELDN Comparison

Compare KELYA & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc.

KELYA

Kelly Services Inc.

HOLD

Current Price

$11.94

Market Cap

340.1M

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.60

Market Cap

300.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYA
ELDN
Founded
1946
2004
Country
United States
United States
Employees
4900
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
340.1M
300.3M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
KELYA
ELDN
Price
$11.94
$3.60
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$15.00
$8.50
AVG Volume (30 Days)
475.6K
963.9K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
30.67
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.98
$1.35
52 Week High
$14.94
$4.60

Technical Indicators

Market Signals
Indicator
KELYA
ELDN
Relative Strength Index (RSI) 68.86 48.91
Support Level $8.30 $3.35
Resistance Level $12.01 $4.09
Average True Range (ATR) 0.44 0.20
MACD 0.01 -0.03
Stochastic Oscillator 84.21 34.09

Price Performance

Historical Comparison
KELYA
ELDN

About KELYA Kelly Services Inc.

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: